Company profile: OncoDNA
1.1 - Company Overview
Company description
- Provider of precision medicine for cancer treatment, leveraging over 60 yearsβ expertise in medical diagnostics and extensive experience in DNA sequencing and diagnostic analyses in oncology.
Products and services
π
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to OncoDNA
GeneDx
HQ: United States
Website
- Description: Provider of genomic diagnostics and data science solutions using artificial intelligence and machine learning to deliver personalized, actionable insights that improve health outcomes. Offers XomeDxXpress rapid whole exome sequencing (provisional results in 7 days, full report in 2 weeks), whole genome sequencing with optional trio testing, and genetic counseling services for patients and healthcare providers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full GeneDx company profile β
Arbor Biotechnologies
HQ: United States
Website
- Description: Provider of next-generation gene editing therapeutics and tools to create targeted genetic medicines for liver and CNS diseases, supported by an AI/ML-powered discovery engine for high-throughput screening. Develops lipid nanoparticle-delivered liver therapies, AAV-delivered CNS therapies, and partners on ex vivo cell-based therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Arbor Biotechnologies company profile β
Bamboo Therapeutics
HQ: United States
Website
- Description: Provider of gene therapy development, research, and manufacturing for rare genetic diseases, advancing the work of Dr. Richard Jude Samulski at UNCβs Gene Therapy Center from the laboratory into human clinical trials to meet drug approval requirements. Operates a Sanford, North Carolina manufacturing complex using specialized methodologies and advanced techniques.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Bamboo Therapeutics company profile β
AccuraGen
HQ: United States
Website
- Description: Provider of cancer early detection solutions: a liquid biopsy platform using unique biochemistry and machine learning to extract cancer signals in plasma for treatment guidance, minimal residue disease detection, and early screening; and CLAmp-seq technology to detect multiple cancer signals in blood and analyze them with machine learning for multi-cancer early detection tests.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full AccuraGen company profile β
HumanCode
HQ: United States
Website
- Description: Provider of next-generation personal genomics applications and a platform using DNA sequencing to deliver personalized insights that help people make better decisions, combining human-centered design, mobile, and machine-learning technologies to reveal the secrets of the human genome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full HumanCode company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for OncoDNA
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to OncoDNA
2.2 - Growth funds investing in similar companies to OncoDNA
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for OncoDNA
4.2 - Public trading comparable groups for OncoDNA
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β